DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Korkola JE, Liu M, Liby T et al.
Detrimental effects of sequential compared to concurrent treatment of pertuzumab plus T-DM1 in HER2+ breast cancer cell lines. San Antonio Breast Cancer Symposium 2014; S6-07.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.